cis-tetracosenoyl sulfatide
Star0
Identification
- Generic Name
- cis-tetracosenoyl sulfatide
- DrugBank Accession Number
- DB04661
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 890.301
Monoisotopic: 889.631283449 - Chemical Formula
- C48H91NO11S
- Synonyms
- 1-(3-O-sulfo-beta-D-galactosyl)-N-[(15Z)-tetracos-15-enoyl]sphingosine
- C24:1 Sulfatide
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UAntigen-presenting glycoprotein CD1d Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as sulfatides. These are an hydrogen sulfate esters of glycosphingolipids.
- Kingdom
- Organic compounds
- Super Class
- Lipids and lipid-like molecules
- Class
- Sphingolipids
- Sub Class
- Glycosphingolipids
- Direct Parent
- Sulfatides
- Alternative Parents
- Glycosyl-N-acylsphingosines / Fatty acyl glycosides of mono- and disaccharides / Alkyl glycosides / Hexoses / O-glycosyl compounds / N-acyl amines / Alkyl sulfates / Sulfuric acid monoesters / Oxanes / Secondary alcohols show 9 more
- Substituents
- Acetal / Alcohol / Aliphatic heteromonocyclic compound / Alkyl glycoside / Alkyl sulfate / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Fatty acyl / Fatty acyl glycoside show 26 more
- Molecular Framework
- Aliphatic heteromonocyclic compounds
- External Descriptors
- N-acyl-beta-D-galactosylsphingosine, galactosylceramide sulfate (CHEBI:41539)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- LH5A9ZGN2U
- CAS number
- 151057-28-2
- InChI Key
- ZZQWQNAZXFNSEP-JCOQVFCVSA-N
- InChI
- InChI=1S/C48H91NO11S/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-38-44(52)49-41(42(51)37-35-33-31-29-27-25-16-14-12-10-8-6-4-2)40-58-48-46(54)47(60-61(55,56)57)45(53)43(39-50)59-48/h17-18,35,37,41-43,45-48,50-51,53-54H,3-16,19-34,36,38-40H2,1-2H3,(H,49,52)(H,55,56,57)/b18-17-,37-35+/t41-,42+,43+,45-,46+,47-,48+/m0/s1
- IUPAC Name
- [(2R,3R,4S,5S,6R)-3,5-dihydroxy-2-{[(2S,3R,4E)-3-hydroxy-2-[(15Z)-tetracos-15-enamido]octadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxan-4-yl]oxidanesulfonic acid
- SMILES
- CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](OS(O)(=O)=O)[C@H]1O)NC(=O)CCCCCCCCCCCCC\C=C/CCCCCCCC
References
- General References
- Not Available
- External Links
- PDB Entries
- 2akr / 3ric / 3rzn / 3s0i / 4apq / 4ei5 / 4gjq / 4mng / 4mq7 / 7ryn
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.000272 mg/mL ALOGPS logP 5.95 ALOGPS logP 10.56 Chemaxon logS -6.5 ALOGPS pKa (Strongest Acidic) -1.9 Chemaxon pKa (Strongest Basic) -0.99 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 10 Chemaxon Hydrogen Donor Count 6 Chemaxon Polar Surface Area 192.08 Å2 Chemaxon Rotatable Bond Count 42 Chemaxon Refractivity 246.11 m3·mol-1 Chemaxon Polarizability 109.49 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption - 0.5051 Blood Brain Barrier - 0.5422 Caco-2 permeable - 0.6582 P-glycoprotein substrate Substrate 0.5682 P-glycoprotein inhibitor I Inhibitor 0.5105 P-glycoprotein inhibitor II Non-inhibitor 0.9566 Renal organic cation transporter Non-inhibitor 0.9423 CYP450 2C9 substrate Non-substrate 0.8338 CYP450 2D6 substrate Non-substrate 0.8043 CYP450 3A4 substrate Substrate 0.5421 CYP450 1A2 substrate Non-inhibitor 0.7937 CYP450 2C9 inhibitor Non-inhibitor 0.7941 CYP450 2D6 inhibitor Non-inhibitor 0.8777 CYP450 2C19 inhibitor Non-inhibitor 0.7427 CYP450 3A4 inhibitor Non-inhibitor 0.8275 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9389 Ames test Non AMES toxic 0.6546 Carcinogenicity Non-carcinogens 0.7757 Biodegradation Not ready biodegradable 0.6675 Rat acute toxicity 2.4728 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.8968 hERG inhibition (predictor II) Non-inhibitor 0.715
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 302.51822 predictedDeepCCS 1.0 (2019) [M+H]+ 304.2419 predictedDeepCCS 1.0 (2019) [M+Na]+ 310.57153 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsAntigen-presenting glycoprotein CD1d
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Receptor activity
- Specific Function
- Antigen-presenting protein that binds self and non-self glycolipids and presents them to T-cell receptors on natural killer T-cells.
- Gene Name
- CD1D
- Uniprot ID
- P15813
- Uniprot Name
- Antigen-presenting glycoprotein CD1d
- Molecular Weight
- 37716.96 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 11, 2007 17:49 / Updated at June 12, 2020 16:52